In a recent global pharma logistics market report, logistics decision makers note a 63% success rate of undamaged goods. However, this makes a third of shipments presumably unsuccessful. Good practice regulations and guidelines have been created to correct this, but they allow for many different methods for managing temperatures in pharma logistics, some of which may not be very effective for their purpose. From both a patient safety and business perspective, real-time monitoring technology eases the mind of the customer as well as supporting specific logistical operations and delivering relevant data in real-time in order to optimise the supply chain.
Ahead of this year's Temperature Control and Logistics forum 2020, Pharma IQ spoke exclusively to Ada Pálmadóttir, MBA, MPharm, Business Development Director, Controlant, and Jessie VanderVeen VP Marketing & Communications, Controlant, on digital technology solutions to deliver on-demand visibility for life science products requiring low temperature control and quality protection.
Download the full interview for the full insight >>
Additional benefits of downloading the full interview:
- Gain expert insights on the key advantages of implementing real-time technology to transform and monitor your supply chain processes
- Exploring how much data is too much and how stakeholders can make sure the right infrastructures are then in place to address supply chain issues
- Solutions for improving data retrieval and removing supply-chain blind spots
A typical excursion can take over 40 labour hours to investigate and involves input from multiple departments. Reducing that time by 10% per investigation through better collaboration efforts can save hundreds of thousands of pounds for a pharmaceutical organisation.
Ahead of this year's Temperature Control and Logistics forum 2020, Pharma IQ spoke exclusively to Saddam Huq, Global QA Senior Manager, Distribution & Cold Chain, GSK Vaccines about temperature excursions on a global scale and managing the risks associated with different regions, freight types and the challenges of data management.
This report also includes additional webinar learnings from Hashim Ahmed, GL Supply Chain Integrity Senior Analyst, GSK, who shares workable CAPAs and best practices for getting to the real root cause of temperature deviations, which remains a fundamental problem within the cold chain.
Download the full interview now >>
The future of the pharma logistics sector will be characterised by solutions that are software driven rather than hardware driven. In this article, with insights from Amy Shortman, Founder and CEO of ASC Associates Ltd we will explore how the latest technologies will affect the sector, including:
• How new technologies will bridge communication between all parties and stakeholders in the supply chain
• What real time and predictive software systems mean for temperature excursion management
• How IoT and blockchain will shape a touchless, wireless, and secure logistics operation offering an ‘immutable level of traceability’ for products
The last mile presents unique challenges for maintaining drug quality and integrity, both in terms of inaccurate planning and a lack of integration between internal systems. In this article, with insights from Henry Moran Chief Operating Officer, ASC Associates Ltd, we explore:
- Who is responsible for the last mile?
- How can you mitigate the two most common causes of disruption in the last mile?
- How will Internet of Things (IoT) shake things up in the last mile?
Multiple factors affect the decision to choose a particular mode of transport for pharmaceuticals. On the back of feedback received on the topic of air freight vs sea freight, Pharma IQ interviewed two industry experts about their thoughts on the continuing importance of air freight in the transportation of temperature controlled pharmaceuticals.